The ‘In Silico’ Advantage: How Lipo405’s Data-First Approach is Changing Wellness R&D
Body: For too long, the supplement industry has operated like a black box, often combining trendy ingredients with little public data to support their synergistic action. Xelyra Biotech is challenging this status quo with a transparent, data-driven methodology used to develop its Lipo405 protocol: the in silico trial. In silico—meaning “performed on computer or via…
